Remove resources glossary
article thumbnail

NHC Comments on Information Collection Request for Drug Price Negotiation by IRA

Putting Patients First Blog

Driven by the work of the Food and Drug Administration on patient-focused drug development (PFDD), many companies in the biopharmaceutical community have devoted significant resources to better understand patient populations and are working to bring to market products that best suit their needs.

article thumbnail

Ovarian cancer, Olivia, and the OCC – part one

pharmaphorum

A gynaecological oncologist perspective Asking Professor Nicole Concin about the scientific development process behind Olivia and the real-world benefit of this resource, Professor Concin told pharmaphorum that the system provides “incredible support” for patients and their families, as well as the whole support network surrounding them. “[For

article thumbnail

NHC Comments on Key Information and Facilitating Understanding in Informed Consent

Putting Patients First Blog

To support these efforts, the NHC suggests that the FDA facilitate access to resources and training for researchers on how to effectively engage with and create materials for diverse populations. This could include workshops, webinars, and online resources that provide insights into cultural competence in research settings.